-
Datamonitor notes knowledge gap, concern over natural personal care products
NEW YORK Many consumers worldwide believe that personal care products formulated with natural ingredients are better for them; however, they still are concerned about product efficacy, and most consider themselves unknowledgeable when it comes to the impact of chemicals on their health, according to recent research by research-firm Datamonitor.
-
FDA approves Par and Tris Pharma's generic Tussionex
WOODCLIFF LAKE, N.J. The Food and Drug Administration has approved a generic treatment for cough and upper respiratory symptoms resulting from colds and allergies made by Par Pharmaceutical and Tris Pharma, Par said Tuesday.
The FDA approved hydrocodone polistirex and chlorpheniramine polistirex extended-release oral suspension. The drug is a generic version of UCB’s Tussionex, which has annual sales of around $226 million, according to IMS Health.